MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
266.17%
Quick Ratio
266.17%
Cash Ratio
109.47%
Debt to Asset Ratio
49.85%
Unit: Thousand (K) dollars
Assets Breakdown
Financial royalty assets, net
Total current assets
Goodwill
Others
Liabilities Breakdown
Long-term debt
Additional paid-in capital
Non-controlling interests
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
586,395
618,696
938,944
631,908
Financial royalty assets
779,844
854,386
860,073
842,938
Available for sale debt securities
21,900
18,800
16,100
13,200
Other royalty income receivable
27,511
29,316
28,901
27,743
Other current assets
10,161
6,893
5,519
4,452
Total current assets
1,425,811
1,528,091
1,849,537
1,520,241
Financial royalty assets, net
16,542,353
16,208,482
15,763,674
15,134,291
Equity securities
173,270
171,312
129,393
110,529
Available for sale debt securities
406,800
419,000
302,500
271,900
Equity method investments
265,697
289,968
290,957
275,914
Goodwill
924,634
924,634
924,634
924,634
Other assets
76,850
79,293
86,585
85,491
Total assets
19,815,415
19,620,780
19,347,280
18,323,000
Distributions payable to non-controlling interests
87,417
72,825
77,222
98,197
Accounts payable and accrued liabilities
25,483
19,404
41,415
20,209
Interest payable
25,302
110,818
29,044
85,609
Current portion of long-term debt
380,000
380,000
380,000
999,436
Other current liabilities
17,480
53,164
3,121
3,075
Total current liabilities
535,682
636,211
530,802
1,206,526
Long-term debt
8,576,443
8,570,917
8,565,735
7,003,063
Accrued compensation liabilities
648,672
577,870
502,938
467,143
Other liabilities
117,785
120,843
126,944
143,328
Total liabilities
9,878,582
9,905,841
9,726,419
8,820,060
Common stock-Common Class A
45
43
44
44
Common stock-Common Class B
0
0
0
0
Common stock-Class RRedeemable Stock
63
63
63
63
Additional paid-in capital
4,384,056
4,123,088
4,112,538
4,127,665
Retained earnings
2,507,091
2,356,318
2,304,314
2,222,750
Non-controlling interests
3,048,287
3,238,039
3,206,513
3,155,030
Treasury interests
2,709
2,612
2,611
2,612
Total shareholders equity
9,936,833
9,714,939
9,620,861
9,502,940
Total liabilities and shareholders equity
19,815,415
19,620,780
19,347,280
18,323,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Financial royalty assets
$779,844K
(8.83%↑ Y/Y)
Cash and cash
equivalents
$586,395K
(-46.09%↓ Y/Y)
Other royalty income
receivable
$27,511K
(15.67%↑ Y/Y)
Available for sale debt
securities
$21,900K
(80.99%↑ Y/Y)
Other current assets
$10,161K
(230.01%↑ Y/Y)
Financial royalty assets,
net
$16,542,353K
(10.05%↑ Y/Y)
Total current assets
$1,425,811K
(-22.65%↓ Y/Y)
Goodwill
$924,634K
Available for sale debt
securities
$406,800K
(85.75%↑ Y/Y)
Equity method
investments
$265,697K
(-20.97%↓ Y/Y)
Equity securities
$173,270K
(22.81%↑ Y/Y)
Other assets
$76,850K
(109.36%↑ Y/Y)
Total assets
$19,815,415K
(12.53%↑ Y/Y)
Total liabilities and
shareholders equity
$19,815,415K
(12.53%↑ Y/Y)
Total shareholders
equity
$9,936,833K
(1.51%↑ Y/Y)
Total liabilities
$9,878,582K
(26.33%↑ Y/Y)
Treasury interests
$2,709K
(2.07%↑ Y/Y)
Additional paid-in capital
$4,384,056K
(4.12%↑ Y/Y)
Non-controlling interests
$3,048,287K
(-1.67%↓ Y/Y)
Retained earnings
$2,507,091K
(1.07%↑ Y/Y)
Long-term debt
$8,576,443K
(29.58%↑ Y/Y)
Accrued compensation
liabilities
$648,672K
Total current
liabilities
$535,682K
(-54.71%↓ Y/Y)
Other liabilities
$117,785K
(558.02%↑ Y/Y)
Common stock-Class
RRedeemable Stock
$63K
(0.00%↑ Y/Y)
Common stock-Common
Class A
$45K
(4.65%↑ Y/Y)
Current portion of
long-term debt
$380,000K
(138.05%↑ Y/Y)
Distributions payable to
non-controlling interests
$87,417K
(-19.65%↓ Y/Y)
Accounts payable and
accrued liabilities
$25,483K
(-32.28%↓ Y/Y)
Interest payable
$25,302K
(31.64%↑ Y/Y)
Other current
liabilities
$17,480K
(-6.02%↓ Y/Y)
Buy us a coffee
1-svg
Royalty Pharma plc (RPRX)
1-svg
Royalty Pharma plc (RPRX)